.jpg)
CME Group Inc. (Nasdaq: CME) today reported that third-quarter GAAP total revenues were $650 million, and GAAP operating income was $401 million from the third quarter of 2008. Third-quarter net income on a GAAP basis was $202 million and diluted earnings per share on a GAAP basis were $3.04.
The 2009 GAAP results reflect the operations of Chicago Mercantile Exchange (CME), Board of Trade of the City of Chicago (CBOT), and New York Mercantile Exchange (NYMEX) and include reductions in net income of $21 million, consisting of an impairment charge on our investment in IMAREX of $19 million and merger-related items of $2 million. The charge for IMAREX, a Norwegian-based freight and energy exchange and interdealer broker, was due to a decline in IMAREX fair value relative to the fair value established at the time of CME Group's acquisition of NYMEX in August 2008. The 2008 GAAP results reflect the operations of both CME and CBOT, as well as the results of NYMEX after August 22, 2008, when the acquisition closed.
Third-quarter pro forma non-GAAP diluted earnings per share were $3.35, down 19 percent compared with the prior-year period. All pro forma results reflect the operations of both CME Group and NYMEX as if they were combined for all periods reported, and third-quarter 2009 pro forma non-GAAP results exclude the impairment charge and merger-related items mentioned above. Total pro forma revenues decreased 17 percent from the prior year to $650 million and increased $2.6 million from second-quarter 2009 revenues. Pro forma operating expenses decreased 10 percent to $244 million, compared with the same period last year. Third-quarter pro forma operating income was $407 million, a decrease of 21 percent from $515 million for the year-ago period.
The company's significant focus on expense management during ongoing challenging market conditions helped drive a strong pro forma operating margin of 63 percent, in line with second-quarter 2009 operating margin, and down from 65 percent from the same period a year ago. Operating margin is defined as operating income as a percentage of total revenues. Third-quarter 2009 pro forma net income decreased 20 percent to $223 million, compared with third-quarter 2008.
All references to volume and rate per contract information in the text of this document exclude our non-traditional TRAKRS products, for which CME Group receives significantly lower clearing fees than other CME Group products, Swapstream, and HuRLO products.
Pro forma measures do not replace and are not a substitute for GAAP financial results. They are provided to improve overall understanding of current financial performance and to provide a meaningful comparison with prior periods. A full reconciliation of third-quarter and first-nine-months 2009 pro forma results to GAAP results is included with the attached financial statements.
"Building on solid third-quarter results, October has been a strong volume month, particularly in foreign exchange and energy," said CME Group Executive Chairman Terry Duffy. "As the economy continues to stabilize, there is room for further organic growth in our core business. At the same time, we are actively working to ensure that the benefits our business model brings to the financial system are communicated to the legislators and regulators who are charged with regulatory reform."
"As part of our global growth strategy, we have continued to invest in enhancing our global marketing and sales staff and expanding our CME ClearPort OTC clearing services across all asset classes," said CME Chief Executive Officer Craig Donohue. "During the quarter we also announced a partnership with Bursa Malaysia to extend our ability to deliver products and services to Asian customers. The strength of our core business and our capacity to deliver high quality, cleared-only offerings, coupled with strategic partnerships around the globe, such as Bursa Malaysia and BM&F Bovespa, position CME Group to compete effectively where, when, and how our customers want."
CME Group Inc. Third-Quarter 2009 Results
Financial Highlights:
GAAP
($s in millions,
except
per share) Q3 FY09 Q3 FY08 Y/Y YTD FY09 YTD FY08 Y/Y
------- ------- --- -------- -------- ---
Revenues $650 $681 -4% $1,945 $1,869 4%
Expenses $249 $260 -4% $759 $705 8%
Operating Income $401 $421 -5% $1,187 $1,164 2%
Operating Margin % 61.7% 61.8% 61.0% 62.3%
Net Income $202 $169 20% $623 $653 -5%
Diluted EPS $3.04 $2.81 8% $9.37 $11.61 -19%
Pro Forma Non-GAAP
($s in millions,
except
per share) Q3 FY09 Q3 FY08 Y/Y YTD FY09 YTD FY08 Y/Y
------- ------- --- -------- -------- ---
Revenues $650 $787 -17% $1,945 $2,360 -18%
Expenses $244 $272 -10% $739 $827 -11%
Operating Income $407 $515 -21% $1,206 $1,532 -21%
Operating Margin % 62.5% 65.5% 62.0% 64.9%
Net Income $223 $278 -20% $660 $844 -22%
Diluted EPS $3.35 $4.13 -19% $9.92 $12.59 -21%
NOTE: See the CME Group Inc. Reconciliation of GAAP to Pro Forma Non-GAAP
Measures for detail related to the adjustments made to reach the pro
forma results.
Third-quarter 2009 average daily volume was 10.1 million contracts, down 23 percent compared with third-quarter 2008. Pro forma clearing and transaction fee revenue was $541 million, down from $665 million in third-quarter 2008, but up one percent from second-quarter 2009. The total pro forma average rate per contract for CME Group increased six percent from third-quarter 2008 to 83 cents, and increased one percent compared with 82 cents in second-quarter 2009. Quotation data fees were down 11 percent to $81 million in the third quarter due primarily to a decrease in screen counts associated with cost-cutting initiatives at customer firms.
Third-quarter 2009 pro forma non-operating expense was $26 million, driven primarily by interest expense and borrowing costs of $32 million related to the NYMEX acquisition, which was partially offset by $8 million of investment income. Additionally, the third-quarter 2009 effective tax rate was 41.4 percent, down from 43.3 percent in third-quarter 2008.
As of September 30, the company had $298 million of cash and marketable securities and $2.5 billion of debt. During the quarter, the company paid down approximately $450 million of debt.
CME Group will hold a conference call to discuss third-quarter 2009 results at 8:30 a.m. Eastern Time today. A live audio Webcast of the call will be available on the Investor Relations section of CME Group's Web site at www.cmegroup.com. An archived recording will be available for up to two months after the call.
CME Group (www.cmegroup.com) is the world's largest and most diverse derivatives marketplace. Building on the heritage of CME, CBOT and NYMEX, CME Group serves the risk management needs of customers around the globe. As an international marketplace, CME Group brings buyers and sellers together on the CME Globex electronic trading platform and on trading floors in Chicago and New York. By acting as the buyer to every seller and the seller to every buyer, CME Clearing virtually eliminates counterparty credit risk. CME Clearing also offers financial safeguards to help mitigate systemic risk, providing the security and confidence market participants need to operate, invest and grow. CME Group offers the widest range of benchmark products available across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, and alternative investment products such as weather and real estate. CME Group is listed on NASDAQ under the symbol "CME."
The Globe logo, CME, Chicago Mercantile Exchange, CME Group, Globex, E-mini and CME ClearPort are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade, Inc. are trademarks of the Board of Trade of the City of Chicago. NYMEX and New York Mercantile Exchange are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All other trademarks are the property of their respective owners. Further information about CME Group (NASDAQ: CME) and its products can be found at www.cmegroup.com.
Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. Among the factors that might affect our performance are: our ability to realize the benefits and control the costs of our merger with NYMEX Holdings, Inc. and our ability to successfully integrate the businesses of CME Group and NYMEX Holdings, including the fact that such integration may be more difficult, time consuming or costly than expected and revenues following the merger may be lower than expected and expected cost savings from the merger may not be fully realized within the expected time frames or at all; increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development and implementation of the enhanced functionality required by our customers; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to continue to generate revenues from our processing services; our ability to maintain existing customers, develop strategic relationships and attract new customers; our ability to expand and offer our products in foreign jurisdictions; changes in domestic and foreign regulations; changes in government policy, including policies relating to common or directed clearing, changes as a result of a harmonization of the regulation of the Securities and Exchange Commission and the U.S. Commodity Futures Trading Commission, or changes relating to the recently enacted or proposed legislation relating to the current economic crisis; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; our ability to generate revenue from our market data that may be reduced or eliminated by the growth of electronic trading or declines in subscriptions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our financial safeguards package to adequately protect us from the credit risks of clearing members; the ability of our compliance and risk management methods to effectively monitor and manage our risks; changes in price levels and volatility in the derivatives markets and in underlying fixed income, equity, foreign exchange and commodities markets; economic, political and market conditions, including the recent volatility of the capital and credit markets and the impact of current economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in trading volume and order transaction traffic without failure or degradation of performance of our systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks and control the costs associated with our acquisition, investment and alliance strategy; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry and customer consolidation; decreases in trading and clearing activity; the imposition of a transaction tax on futures and options on futures transactions; the unfavorable resolution of material legal proceedings, the seasonality of the futures business; and changes in the regulation of our industry with respect to speculative trading in commodity interests and derivatives contracts. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, including our most recent periodic reports filed on Form 10-K and Form 10-Q, which are available in the Investor Relations section of the CME Group Web site. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
CME-E
CME Group Inc. and Subsidiaries
Consolidated Balance Sheets
(in millions)
September 30, December 31,
2009 2008
---- ----
ASSETS
Current Assets:
Cash and cash equivalents $204.1 $297.9
Collateral from securities lending - 426.9
Marketable securities, including pledged
securities 93.7 310.1
Accounts receivable, net of
allowance 264.0 234.0
Other current assets 119.6 189.1
Cash performance bonds and security
deposits 6,824.8 17,653.5
------- --------
Total current assets 7,506.2 19,111.5
Property, net of accumulated
depreciation and amortization 726.9 707.2
Intangible assets - trading products 16,982.0 16,982.0
Intangible assets - other, net of
accumulated amortization 3,277.1 3,369.4
Goodwill 7,549.3 7,519.2
Other assets 478.1 469.4
----- -----
Total Assets $36,519.6 $48,158.7
========= =========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable $36.1 $71.0
Payable under securities lending
agreements - 456.8
Short-term debt 299.7 249.9
Other current liabilities 157.8 211.8
Cash performance bonds and security
deposits 6,824.8 17,653.5
------- --------
Total current liabilities 7,318.4 18,643.0
Long-term debt 2,239.3 2,966.1
Deferred tax liabilities 7,669.9 7,728.3
Other liabilities 161.7 132.7
----- -----
Total Liabilities 17,389.3 29,470.1
Shareholders' equity 19,130.3 18,688.6
-------- --------
Total Liabilities and Shareholders'
Equity $36,519.6 $48,158.7
========= =========
CME Group Inc. and Subsidiaries
Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended Nine Months Ended
September 30, September 30,
2009 2008 2009 2008
---- ---- ---- ----
Revenues
Clearing and transaction fees $540.6 $558.7 $1,605.2 $1,542.3
Quotation data fees 81.4 75.7 249.0 192.3
Processing services 0.1 17.9 0.3 53.9
Access and communication fees 11.4 10.9 34.5 32.2
Other 16.9 17.7 56.3 48.5
---- ---- ---- ----
Total Revenues 650.4 680.9 1,945.3 1,869.2
Expenses
Compensation and benefits 87.3 84.5 262.0 231.4
Communications 11.5 11.5 35.5 39.1
Technology support services 11.3 11.9 34.7 47.0
Professional fees and outside
services 17.9 17.0 61.9 47.8
Amortization of purchased
intangibles 30.7 29.1 94.5 63.2
Depreciation and amortization 32.3 34.1 93.4 102.9
Occupancy and building operations 19.1 18.9 57.3 52.9
Licensing and other fee
agreements 21.2 19.3 67.5 44.8
Restructuring 0.6 0.1 5.2 2.1
Other 17.1 33.8 46.7 73.7
---- ---- ---- ----
Total Expenses 249.0 260.2 758.7 704.9
Operating Income 401.4 420.7 1,186.6 1,164.3
Non-Operating Income and Expense
Investment income 10.5 18.0 22.4 41.4
Impairment of long-term
investment (22.4) - (22.4) -
Gains (losses) on derivative
investments - 7.4 - (7.8)
Securities lending interest
income - 8.6 2.8 32.2
Securities lending interest and other
costs - (28.9) (0.1) (48.2)
Interest and other borrowing
costs (32.1) (17.9) (103.2) (21.6)
Guarantee of exercise right
privileges - 8.0 - 12.8
Equity in losses of unconsolidated
subsidiaries (1.6) (20.0) (4.5) (27.9)
Other income (expense) - 0.1 (0.4) (8.4)
--- --- ---- ----
Total Non-Operating (45.6) (24.7) (105.4) (27.5)
Income Before Income Taxes 355.8 396.0 1,081.2 1,136.8
Income tax provision (153.5) (227.3) (458.0) (483.4)
------ ------ ------ ------
Net Income $202.3 $168.7 $623.2 $653.4
====== ====== ====== ======
Earnings per Common Share:
Basic $3.05 $2.82 $9.39 $11.66
Diluted 3.04 2.81 9.37 11.61
Weighted Average Number of Common Shares:
Basic 66,384 59,870 66,339 56,054
Diluted 66,573 60,086 66,514 56,302
CME Group Inc. and Subsidiaries
Pro Forma Non-GAAP Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in thousands)
Quarter Ended Nine Months Ended
September 30, September 30,
2009 2008 2009 2008
---- ---- ---- ----
Revenues
Clearing and transaction fees $540.6 $665.2 $1,605.2 $2,008.2
Quotation data fees 81.4 91.6 249.0 261.4
Processing services 0.1 0.6 0.3 1.6
Access and communication fees 11.4 11.1 34.5 33.0
Other 16.9 18.3 56.3 55.6
---- ---- ---- ----
Total Revenues 650.4 786.8 1,945.3 2,359.8
Expenses
Compensation and benefits 84.5 93.4 257.9 277.5
Communications 11.5 12.1 35.5 42.3
Technology support services 11.3 13.1 34.7 52.6
Professional fees and outside
services 16.4 18.4 56.2 56.2
Amortization of purchased
intangibles 30.5 31.3 91.4 92.4
Depreciation and amortization 32.3 34.8 93.4 105.5
Occupancy and building
operations 19.1 21.2 57.3 63.9
Licensing and other fee
agreements 21.2 25.2 67.5 70.7
Other 16.8 22.3 45.5 66.3
---- ---- ---- ----
Total Expenses 243.6 271.8 739.4 827.4
Operating Income 406.8 515.0 1,205.9 1,532.4
Non-Operating Income and Expense
Investment income 7.7 22.4 18.3 54.7
Gains (losses) on derivative
investments - 0.1 - 0.2
Securities lending interest
income - 10.5 2.8 46.7
Securities lending interest and
other costs - (15.0) (0.1) (44.7)
Interest and other borrowing
costs (32.1) (38.1) (103.2) (114.3)
Equity in losses of unconsolidated
subsidiaries (1.6) (5.1) (4.5) (17.2)
---- ---- ---- -----
Total Non-Operating (26.0) (25.2) (86.7) (74.6)
Income Before Income Taxes 380.8 489.8 1,119.2 1,457.8
Income tax provision (157.8) (212.0) (459.3) (613.7)
------ ------ ------ ------
Net Income $223.0 $277.8 $659.9 $844.1
====== ====== ====== ======
Earnings per Diluted Common Share $3.35 $4.13 $9.92 $12.59
Weighted Average Number of Diluted
Common Shares(1) 66,573 67,325 66,514 67,062
Note: All pro forma results for CME Group assume the acquisition of
NYMEX was completed as of the beginning of the period presented. See
CME Group Inc. Reconciliation of GAAP to Pro Forma Non-GAAP Measures for
detail on all of the adjustments made to reach the pro forma results.
(1) Weighted average number of diluted common shares includes
merger-related shares converted or issued for the entire
period reported.
CME Group Inc. and Subsidiaries
Reconciliation of GAAP to Pro Forma Non-GAAP Measures
(in millions)
Quarter Ended Nine Months Ended
September 30, September 30,
2009 2008 2009 2008
---- ---- ---- ----
GAAP Results
Revenues $650.4 $680.9 $1,945.3 $1,869.2
Expenses 249.0 260.2 758.7 704.9
----- ----- ----- -----
Operating income 401.4 420.7 1,186.6 1,164.3
Non-operating income and expense (45.6) (24.7) (105.4) (27.5)
----- ----- ------ -----
Income before income taxes 355.8 396.0 1,081.2 1,136.8
Income tax provision (153.5) (227.3) (458.0) (483.4)
------ ------ ------ ------
Net Income $202.3 $168.7 $623.2 $653.4
====== ====== ====== ======
Pro Forma Adjustments
Revenues:
NYMEX pre-merger revenue $- $124.3 $- $544.0
Intercompany revenue elimination(1) - (10.7) - (45.7)
FXMarketSpace write down - (7.7) - (7.7)
--- ---- --- ----
Total Pro Forma Revenue Adjustment - 105.9 - 490.6
Expenses:
NYMEX pre-merger expense - 81.5 - 229.2
Intercompany expense elimination (1) - (10.8) - (45.8)
Deferred compensation gain/loss
reclass(2) (2.8) 2.9 (4.1) 4.5
Swapstream write down (0.3) (14.3) (0.3) (14.3)
Amortization of intangibles (3) - 5.6 (2.8) 32.6
Depreciation adjustment from
building life change (4) - 1.0 - 4.0
Loss on sale of metals - (2.8) - (2.8)
FXMarketSpace write down - (2.6) - (2.6)
Other (5) (2.3) (48.9) (12.1) (82.3)
---- ----- ----- -----
Total Pro Forma Expense Adjustment (5.4) 11.6 (19.3) 122.5
---- ---- ----- -----
Adjustment to operating income 5.4 94.3 19.3 368.1
Non-operating income and expense:
NYMEX premerger non-operating income - (0.3) - 32.4
Interest on debt acquired for NYMEX
deal - (19.3) - (88.6)
Deferred compensation gain/loss
reclass(2) (2.8) 2.9 (4.1) 4.5
Equity investment unusual gain/
loss(6) - 15.9 - (14.7)
Securities lending writedown - 15.7 - 15.7
ERP Guarantee (7) - (8.0) - (12.8)
BM&F Bovespa (8) - (7.4) - 16.4
Green Exchange(9) - - 0.4 -
IMAREX impairment 22.4 - 22.4 -
---- --- ---- ---
Total Pro Forma Non-Operating Income
and Expense Adjustment 19.6 (0.5) 18.7 (47.1)
---- ---- ---- -----
Adjustment to income before income
taxes 25.0 93.8 38.0 321.0
Adjustment to income tax provision (4.3) 15.3 (1.3) (130.3)
---- ---- ---- ------
Adjustment to net income $20.7 109.1 $36.7 $190.7
===== ===== ===== ======
Pro Forma Non-GAAP Results
Revenues 650.4 786.8 1,945.3 2,359.8
Expenses 243.6 271.8 739.4 827.4
------ ------ ------ ------
Operating income 406.8 515.0 1,205.9 1,532.4
Non-operating income and expense (26.0) (25.2) (86.7) (74.6)
----- ------ ----- -----
Income before income taxes 380.8 489.8 1,119.2 1,457.8
Income tax provision(10) (157.8) (212.0) (459.3) (613.7)
------ ------- ------ ------
Net Income $223.0 $277.8 $659.9 $844.1
===== ====== ===== =====
Notes:
(1) Eliminate processing services provided prior to the NYMEX
acquisition.
(2) Remove gains and losses related to a deferred compensation plan
that are recorded in compensation with a corresponding offset in
investment income.
(3) Add amortization of intangible assets recorded in purchase of
NYMEX.
(4) Adjust depreciation for changes in value and useful life of
building acquired from NYMEX.
(5) Reverse effect of restructuring, accelerated depreciation,
integraton and legal expenses related to the merger with CBOT
and the acquisition of NYMEX. Also removes other merger-related
transaction costs that were expensed and transaction costs related
to the acquisition of CMA.
(6) Write-down of Optionable as well as a gain related to TSX Group.
(7) Reverse impact of exercise right privilege guarantee.
(8) Reverse derivative gains/losses and transaction costs related to the
BM&F/Bovespa investment.
(9) Reverse transaction costs related to the investment in Green
Exchange.
(10) Pro forma adjustments are tax effected at CME Group's estimated
statutory tax rate.
CME Group Inc.
Quarterly Operating Statistics
3Q 2008 4Q 2008 1Q 2009 2Q 2009 3Q 2009
------- ------- ------- ------- -------
Trading Days 64 64 61 63 64
Quarterly Average Daily Volume (ADV)
CME Group ADV (Legacy CME, CBOT, NYMEX and COMEX combined, in thousands)
Product Line 3Q 2008 4Q 2008 1Q 2009 2Q 2009 3Q 2009
------------ ------- ------- ------- ------- -------
Interest rates 6,030 3,692 3,843 4,389 4,422
Equities 3,842 3,993 3,537 2,988 2,656
Foreign exchange 710 481 507 568 660
Energy (including ClearPort) 1,475 1,290 1,524 1,396 1,484
Commodities & alternative
investments 822 691 685 818 708
Metals (including ClearPort) 265 184 215 190 201
--- --- --- --- ---
Total 13,145 10,331 10,311 10,349 10,132
Venue
-----
Open outcry 1,811 1,456 1,338 1,431 1,264
Electronic 10,686 8,272 8,223 8,266 8,267
Privately negotiated 203 168 164 173 147
--- --- --- --- ---
Exchange-traded Total 12,700 9,895 9,726 9,871 9,679
CME ClearPort 445 436 586 478 453
--- --- --- --- ---
Total 13,145 10,331 10,311 10,349 10,132
Average Rate Per Contract (RPC)
CME Group RPC (Legacy CME, CBOT, NYMEX and COMEX combined)
Product Line 3Q 2008 4Q 2008 1Q 2009 2Q 2009 3Q 2009
------------ ------- ------- ------- ------- -------
Interest rates $0.521 $0.569 $0.532 $0.525 $0.505
Equities 0.720 0.748 0.716 0.712 0.722
Foreign exchange 0.936 0.894 0.918 0.901 0.853
Energy (including ClearPort) 1.629 1.773 1.608 1.653 1.694
Commodities & alternative
investments 1.154 1.154 1.108 1.130 1.199
Metals (including ClearPort) 1.762 1.879 1.858 1.808 1.849
----- ----- ----- ----- -----
Average RPC $0.790 $0.866 $0.839 $0.823 $0.834
Venue
-----
Exchange-traded $0.743 $0.801 $0.777 $0.765 $0.765
CME ClearPort 2.139 2.352 1.874 2.031 2.304
Note: All CME Group volume and rate per contract data is based upon pro
forma results, including the operations of CME Group and NYMEX as if they
were combined for the entire period reported. All data excludes our non-
traditional TRAKRS products, for which CME Group receives significantly
lower clearing fees than other CME Group products. Additionally, all
data excludes Swapstream and HuRLO products.
Note: Average daily volume and rate per contract figures for prior
periods have been revised due to standardizing NYMEX reporting
conventions to follow CME Group's treatment of post-trade transactions
such as exercises, assignments and deliveries.
